AzTrials
AzTrials

Wrist Internal DerangementNCT07826208

Added Diagnostic Value of CT Arthrography to MR Arthrography in Wrist Internal Derangement

A study testing Combined CT Arthrography and MR Arthrography in people with Wrist Internal Derangement and Triangular Fibrocartilage Complex Tears, run by Assiut University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Official record
Search all trials

Trial summary

The wrist is a complex joint made up of small bones, cartilage, and stabilizing ligaments, including the triangular fibrocartilage complex (TFCC) and intrinsic carpal ligaments. Because these structures are small and intricate, diagnosing internal joint damage (internal derangement) after trauma or chronic pain can be… Read more about this study

Who is it for?
Ages 15 to 60 years
What is being tested?
Combined CT Arthrography and MR Arthrography
Type of treatment
Injection or infusion
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
No sites listed yet
Study dates
Oct 2026to Nov 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 to 60 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Patients aged 15 to 60 years.
  • Clinically suspected ligamentous, cartilage, tendon, or occult osseous wrist injury.
  • Patients scheduled for MR arthrography of the wrist.

Who cannot join

  • History of previous wrist surgery.
  • Acute fractures requiring emergency management.
  • Active wrist infection.
  • Contraindications to iodinated or gadolinium-based contrast agents.
  • Regional metallic implants causing significant imaging artifacts.
  • Pregnancy.

About this study

Official title: Added Diagnostic Value of CT Arthrography to MR Arthrography in Suspected Wrist Internal Derangement

The wrist is a complex joint made up of small bones, cartilage, and stabilizing ligaments, including the triangular fibrocartilage complex (TFCC) and intrinsic carpal ligaments. Because these structures are small and intricate, diagnosing internal joint damage (internal derangement) after trauma or chronic pain can be challenging.

Magnetic resonance arthrography (MRA), an imaging scan performed after injecting a contrast dye into the joint, is widely used because it shows soft tissues clearly. However, MRA can sometimes miss subtle bone fragments, cartilage defects, or partial ligament tears due to lower spatial resolution. Computed tomography arthrography (CTA) provides higher-detail spatial imaging and excels at identifying small bone injuries and ligament tears, though it offers less soft-tissue contrast than MRI.

Read more

The purpose of this study is to determine whether performing CT arthrography in addition to MR arthrography improves the detection and characterization of internal wrist pathologies compared with MR arthrography alone.

Participants enrolled in this study will:

  • Undergo a clinical history taking and examination regarding their wrist symptoms.
  • Receive an ultrasound-guided injection into the radiocarpal joint using a sterile mixture containing iodinated contrast, gadolinium contrast, saline, and a local numbing medication (xylocaine).
  • Undergo a high-resolution CT scan of the wrist immediately following the injection.
  • Undergo a 1.5T MR arthrography scan.

Researchers will compare the findings between the two imaging techniques to evaluate how often adding CT arthrography identifies additional lesions that were occult or inconclusive on MR arthrography.

Being tested
Combined CT Arthrography and MR Arthrography
Keywords
CT Arthrography, MR Arthrography, Computed Tomography Arthrography, Magnetic Resonance Arthrography, Triangular Fibrocartilage Complex, Scapholunate Ligament, Lunotriquetral Ligament, Ultrasound Guided Injection, Wrist Joint, Carpal Ligaments
Medical subject headings
Wrist Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Combined CT Arthrography and MR ArthrographyDiagnostic test

    Under high-resolution ultrasound guidance, an intra-articular radiocarpal injection of approximately 5 mL is administered using a sterile mixture of iodinated contrast, gadolinium-based contrast, sterile saline, and xylocaine. Immediately following injection, high-resolution CT arthrography is performed with 0.6 mm slice thickness and multiplanar reconstruction in axial, coronal, and sagittal planes. Participants subsequently undergo 1.5T MR arthrography using coronal T2 SPIR (pre-contrast) and axial, coronal, and sagittal T1 SPIR sequences (post-contrast) using a dedicated wrist coil to evaluate internal derangement.

Study groups in NCT07826208
Study groupRoleWhat they receive
Combined CT and MR ArthrographyExperimentalParticipants with clinically suspected wrist internal derangement receive an ultrasound-guided intra-articular injection into the radiocarpal joint using a combined mixture of iodinated contrast, gadolinium-based contrast, sterile saline, and xylocaine. Immediately following the injection, participants undergo high-resolution computed tomography arthrography (HRCT) of the affected wrist. This is followed by 1.5T magnetic resonance arthrography (MRA) with pre-contrast and post-contrast T1 SPIR sequences in axial, coronal, and sagittal planes to assess wrist internal derangement.
Receives: Diagnostic Test: Combined CT Arthrography and MR Arthrography

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Percentage of Patients With Additional Wrist Pathologies Detected by Adding CT Arthrography to MR Arthrography

    Assessed as the proportion of participants in whom CT arthrography identifies additional internal derangement lesions (including intrinsic scapholunate and lunotriquetral ligament tears, central triangular fibrocartilage complex tears, cartilage defects, and occult osseous abnormalities) that were missed, occult, or inconclusive on MR arthrography alone.

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Sep 2026
  2. Study startOct 2026 (estimated)
  3. Primary completionOct 2027 (estimated)
  4. Study completionNov 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07826208
Sponsor's protocol ID
CTA & MRA in Wrist Derangement
Status last verified
Sep 2026
First submitted
13 Sep 2026
Last updated
17 Sep 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Combined CT Arthrography and MR Arthrography in people with Wrist Internal Derangement and Triangular Fibrocartilage Complex Tears, run by Assiut University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 17 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Percentage of Patients With Additional Wrist Pathologies Detected by Adding CT Arthrography to MR Arthrography (time frame: Baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in